Skip to main content

Pardes Biosciences, Inc.

PRDSDelisted Aug 31, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001822711

Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Pardes Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of PRDS: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders041+41
Shares035.0M+35.0M
Value$0$573.0M+$573.0M

New holders (41)

Institutions that held Pardes Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to PRDS in Q4 2021
InstitutionSharesValue% of portfolio
Foresite Capital Management V, LLC9,400,515$153.9M37.81%
Foresite Capital Opportunity Management V, LLC5,227,307$85.6M57.37%
Price T Rowe Associates Inc3,212,475$52.1M0.00%
Ra Capital Management, L.P.3,127,038$51.2M0.90%
Frazier Management LLC2,457,507$40.2M3.10%
EcoR1 Capital, LLC1,597,139$26.1M0.84%
Arena Capital Advisors, LLC- CA1,187,449$19.4M1.79%
Platinum Investment Management Ltd1,087,070$17.8M0.50%
JS Capital Management LLC1,000,000$16.4M0.74%
Chescapmanager LLC971,114$15.9M2.41%
Janus Henderson Group PLC570,560$9.29M0.00%
Monashee Investment Management LLC500,000$8.19M2.02%
Adage Capital Partners GP, L.L.C.450,000$7.37M0.01%
Lynx1 Capital Management LP401,593$6.57M5.74%
Franklin Resources Inc400,000$6.55M0.00%
Harvard Management Co Inc400,000$6.55M0.61%
Ikarian Capital, LLC400,000$6.55M1.87%
PFM Health Sciences, LP361,528$5.92M0.21%
Sio Capital Management, LLC312,438$5.12M1.56%
Citadel Advisors LLC300,000$4.91M0.01%
Millennium Management LLC234,398$3.84M0.00%
DAFNA Capital Management LLC233,500$3.82M0.96%
Alyeska Investment Group, L.P.225,000$3.68M0.04%
Wellington Management Group LLP207,878$3.40M0.00%
Altium Capital Management LP200,000$3.27M0.92%
Point72 Asset Management, L.P.137,234$2.25M0.01%
Altai Capital Management, L.P.100,000$1.64M0.98%
TD Asset Management Inc82,498$1.35M0.00%
HRT Financial LP69,962$1.15M0.01%
Ghost Tree Capital, LLC50,000$819.0K0.31%
Boothbay Fund Management, LLC44,197$724.0K0.02%
D. E. Shaw & Co., Inc.38,039$623.0K0.00%
Harvest Management LLC20,000$327.0K0.25%
Wells Fargo & Company19,267$315.0K0.00%
Penserra Capital Management LLC3,317$54.0K0.00%
Cubist Systematic Strategies, LLC2,206$36.0K0.00%
American Portfolios Advisors1,000$16.4K0.00%
National Bank of Canada1,000$16.0K0.00%
Tower Research Capital LLC (TRC)281$5.00K0.00%
UBS Group AG150$2.00K0.00%
Point72 Hong Kong Ltd34$1.00K0.00%

Sold out (0)

Institutions that held Pardes Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

None.